Indonesia Drafts List of Pharmaceutical Raw Materials Used in Health Supplements

On January 27, 2026, the Indonesian Food and Drug Authority (BPOM) initiated a public consultation on the Draft Decree of the Head of BPOM concerning the List of Pharmaceutical Raw Materials Used in Natural Ingredient Medicines, Health Supplements, Quasi Drugs, and Certain Cosmetic Preparations. The draft aims to provide legal certainty and a clear reference for the industry by establishing official lists of pharmaceutical raw materials used in these products. The deadline for submitting feedback is February 10, 2026.

The draft decree follows BPOM Regulation No. 26 of 2025 on the Risk Assessment of Ingredients Used in Natural Medicines, Health Supplements, Quasi-drugs, and Certain Cosmetic Products, which entered into force on October 3, 2025. That regulation requires ingredients used in certain high-risk dosage forms to meet pharmaceutical-grade standards.

The appendix outlines 14 pharmaceutical raw materials that are regulated for use in health supplements in the form of oral liquid. Notably, the draft stipulates that all listed raw materials must comply with the quality standards of the Indonesian Pharmacopoeia.